We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
World of Expats is a business designed to support expats with the tools, services and information they need to make the most of their live as an expat.
days to go: Expired investment: £49,153
The Asset Exchange Ltd is an asset-backed lender within the UK used car finance market providing cars and loans to borrowers who are unable to use traditional lending sources for vehicle finance. They use compliant Hire Purchase Agreements which provides customers with high levels of consumer protection.    
days to go: Expired investment: £63,064
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
days to go: Expired investment: £894,056
Using artificial intelligence to accurately match a person's CV with a business's job requirements. Recruitment Smart have developed SniperAI, a tool created by specialists and a researcher from Carnegie Mellon University to quickly search and scan the ideal candidate for a specific job role. This technology can be integrated into a company's job listings to automatically screen submitted CVs and returns a suitability score. In addition, as HR departments are under constant scrutiny to provide information on equality in the workplace, SniperAI can offer a list of appropriate candidates without bias. Recruitment Smart will generate revenue from initial set-up costs and licensing the product to businesses.
days to go: Expired investment: £272,650
WeSwap is an award-winning P2P travel money platform that enables travellers around the globe to exchange currency in a hassle-free and transparent manner. The company has over 500,000 users who have swapped and spent more than £255 million in 197 countries and territories. WeSwap has also launched a portfolio of travel money products such as travel cash and buyback. The company has also garnered over 3000 reviews and earned a five-star rating on Trustpilot. Furthermore, WeSwap has won "Best Travel Money Provider" title for two consecutive years at the British Bank Awards. With the proceeds, the company will launch in international markets, make new products and develop new partnerships.
days to go: Expired investment: £2,520,786
Business Finance Market (BFM) is a financial technology platform that stimulates the market towards Small and Medium Enterprises (SMEs) lending via data in the UK. BFM claims that SMEs are gradually being excluded from mainstream banking. The company cites that in 1988, 40% of all bank lending went to SMEs. BFM points out that lending today is closer to 4% with an estimated £22 billion funding gap to the 5.9 million UK SMEs. BFM asserts that almost 90% of SME loan applications are stuck due to a lack of choice and transparency when it comes to securing finance. BFM aspires to solve this dilemma. It states that its technology allows SMEs to experience quicker finance decisions based on true addressable market access and allows lenders and intermediaries access to its platform to help manage the end-to-end application process, improve deal flow, and deliver faster credit decisions. BFM intends to exit via a trade sale within the financial sector.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph